Does size matter? An investigation into the Rey Complex Figure in a pediatric clinical sample.

Appl Neuropsychol Child

a Department of Neuropsychology , Westside NeuroRehabilitation Services/Goodwill Industries , Lewiston , Maine.

Published: July 2014

The Rey Complex Figure Test (RCF) copy requires visuoconstructional skills and significant attentional, organizational, and problem-solving skills. Most scoring schemes codify a subset of the details involved in figure construction. Research is unclear regarding the meaning of figure size. The research hypothesis of our inquiry is that size of the RCF copy will have neuropsychological significance. Data from 95 children (43 girls, 52 boys; ages 6-18 years) with behavioral and academic issues revealed that larger figure drawings were associated with higher RCF total scores and significantly higher scores across many neuropsychological tests including the Wechsler Individual Achievement Test-Second Edition (WIAT-II) Word Reading (F = 5.448, p = .022), WIAT-II Math Reasoning (F = 6.365, p = .013), Children's Memory Scale Visual Delay (F = 4.015, p = .048), Trail-Making Test-Part A (F = 5.448, p = .022), and RCF Recognition (F = 4.862, p = .030). Results indicated that wider figures were associated with higher cognitive functioning, which may be part of an adaptive strategy in helping facilitate accurate and relative proportions of the complex details presented in the RCF. Overall, this study initiates the investigation of the RCF size and the relationship between size and a child's neuropsychological profile.

Download full-text PDF

Source
http://dx.doi.org/10.1080/21622965.2012.690921DOI Listing

Publication Analysis

Top Keywords

rey complex
8
complex figure
8
rcf copy
8
associated higher
8
f = 5448 p = 022
8
rcf
6
size
5
figure
5
size matter?
4
matter? investigation
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.

Background: [F]FDG PET is essential since it allows us to differentiate between different dementia disorders/types, revealing distinct neurodegenerative patterns in those predisposed to the condition. Individuals with Autosomal Dominant Alzheimer's Disease (ADAD) have a predictable age of onset, enabling the study of cognitive and pathological changes before clinical manifestation. Our objective was to investigate temporal course and regional links between cognition and glucose metabolism as a measure of early synaptic impairment in ADAD.

View Article and Find Full Text PDF

Background: Plasma biomarkers have emerged as a promising tool to detect the presence of Alzheimer's disease (AD) when cognitive symptoms have not yet emerged. However, there is also a pressing need to detect and track subtle cognitive change at the preclinical stage of AD for population screening purposes and to monitor disease progression at scale. A potential solution is remote cognitive assessment, yet it is still not extensively employed.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, University of Southern California, Marina del Rey, CA, USA.

Background: We present the results of a task-based fMRI study in early Alzheimer's disease (mild cognitive impairment, MCI and mild Alzheimer's disease, AD) using a novel-fMRI memory paradigm suitable for use in patients with significant cognitive impairment having difficulties with remembering complex instructions.

Method: The study samples comprised 65 patients with early AD(MCI n = 42; 21 males; mild AD n = 23; 16 males) and 26(14 males) elderly cognitively healthy control(eCHC) participants. The incidental encoding phase of the paradigm (7 minutes) comprised 110 trials of common objects (55 living and 55 non-living trials which included 4 objects repeated 6 times each and 1 object repeated 5 times) while the intentional retrieval phase of the paradigm (7 minutes) comprised 55 trials of the 5 objects encoded during the previous phase(repeated 11 times each), and 55 new objects.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Stanford University, Stanford, CA, USA.

Background: Recent advancements in molecular positron emission tomography (PET) enable precise tracking of tau pathology in Alzheimer's disease (AD). Tau pathology typically begins focally in the medial temporal lobe, rapidly expanding due to amyloid-β (Aβ) influence. This expansion may lead to neurodegeneration along connected pathways to the tau epicenters, resulting in cognitive decline.

View Article and Find Full Text PDF

Background: Chronic conditions such as obesity, dyslipidemia, insulin resistance and metabolic syndrome are found with increased prevalence in older adults and are investigated as risk factors of Alzheimer's disease (AD). The exact mechanisms by which such conditions may act on the brain to promote AD pathogenesis are still unknown. We aimed to investigate the relationship between peripheral markers of metabolic function, including adiponectin, fibroblast growth factor 21 (FGF21) and insulin-like growth factor binding protein 2 (IGFBP2), and AD-associated cognitive decline.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!